Recruiting

A Study of Tirzepatide in Overweight and Very Overweight Participants

I8F-MC-GPHH - ClinicalTrials.gov - NCT04311411

The main purpose of this study is to measure the effect of tirzepatide on food intake in participants who are overweight or very overweight. The study will also use imaging to learn more about how tirzepatide affects specific parts of the brain. The effect of tirzepatide on appetite will also be studied.
How long will I be in the trial?
The study will last up to about four months and will include up to 14 visits to the study center.
Email
Recruiting

A Study of Tirzepatide in Overweight and Very Overweight Participants

I8F-MC-GPHH - ClinicalTrials.gov - NCT04311411

The main purpose of this study is to measure the effect of tirzepatide on food intake in participants who are overweight or very overweight. The study will also use imaging to learn more about how tirzepatide affects specific parts of the brain. The effect of tirzepatide on appetite will also be studied.
How long will I be in the trial?
The study will last up to about four months and will include up to 14 visits to the study center.
Email

Key Requirements

Age :

18-65

Sex:

All

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18-65

Sex

All

Participants must

Participants must be overweight or very overweight

Participants must have stable body weight over the last month

Participants must agree to commit to and undergo study procedures as explained by clinic study staff

Participants must NOT

Participants must not have undergone weight loss surgery (e.g. stomach stapling, lapbanding)

Participants must not have been diagnosed as having diabetes

Participants must not have used or intend to use weight loss drugs

Participant must not have magnetic implants or suffer from a fear of being in an enclosed space

Female participants must not be pregnant or breastfeeding

Trial Summary

Conditions the trial is for

Very Overweight

What the trial is testing?

Tirzepatide, Placebo, Liraglutide

Could I receive a Placebo?

yes

Enrollment Goal

150

Trial Dates

August 2020 - April 2022

Trial Phase

1

Enter your postal code to find the nearest site

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18-65

Sex

All

Participants must

Participants must be overweight or very overweight

Participants must have stable body weight over the last month

Participants must agree to commit to and undergo study procedures as explained by clinic study staff

Participants must NOT

Participants must not have undergone weight loss surgery (e.g. stomach stapling, lapbanding)

Participants must not have been diagnosed as having diabetes

Participants must not have used or intend to use weight loss drugs

Participant must not have magnetic implants or suffer from a fear of being in an enclosed space

Female participants must not be pregnant or breastfeeding

Trial Summary

Conditions the trial is for

Very Overweight

What the trial is testing?

Tirzepatide, Placebo, Liraglutide

Could I receive a Placebo?

yes

Enrollment Goal

150

Trial Dates

August 2020 - April 2022

Trial Phase

1

Not the right fit? Sign up to receive updates on new trials.

Trial Locations

Hide locations not currently recruiting

Enter your postal code to see sites near you

Very Overweight Resources

Clinical Trial Participation: What to Expect

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study in people that helps to determine if and how a drug or therapy works. These can also be called clinical studies, or clinical research. Clinical research helps us answer specific questions about an investigational drug , such as: Is it effective? Is it more effective than another established treatment? Is it safe and/or what are its side effects?